Unique ID issued by UMIN | UMIN000040450 |
---|---|
Receipt number | R000046168 |
Scientific Title | Prospective Observational Study of Nutritional/Immunologic Indices as Predictive Biomarkers to Anti-PD-1 Drugs in Non-small-Cell Lung Cancer |
Date of disclosure of the study information | 2020/05/21 |
Last modified on | 2023/11/21 10:12:21 |
Prospective Observational Study of Nutritional/Immunologic Indices as Predictive Biomarkers to Anti-PD-1 Drugs in Non-small-Cell Lung Cancer
ICI-PREDICT study
Prospective Observational Study of Nutritional/Immunologic Indices as Predictive Biomarkers to Anti-PD-1 Drugs in Non-small-Cell Lung Cancer
ICI-PREDICT study
Japan |
Non-small cell lung cancer
Pneumology |
Malignancy
NO
The aim of this prospective study is to investigate the clinical impact of pre-treatment nutritional/immunologic indices on the outcomes of patients with advanced non-small cell lung cancer who are treated with immune checkpoint inhibitors. The relationship between early post-treatment changes in nutritional/immunologic indices and outcomes will also be analyzed in the study.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Progression-free survival
Overall survival
Response rate
Disease control rate
Cancer-specific progression-free survival
Cancer-specific overall survival
Safety
Observational
20 | years-old | <= |
Not applicable |
Male and Female
・Pathologically confirmed non-small cell lung cancer (cytology or histology)
・Available programmed cell death-ligand 1 expression on tumor cells (tumor proportion score)
・Any target lesions designated by Response Evaluation Criteria in Solid Tumors version 1.1
・Minimum age of 20 years old
・Stage IV disease or Stage III disease not applicable for definitive chemoradiotherapy
・Treatment with checkpoint inhibitors (monotherapy or combined with chemotherapy) as 1st line therapy
・Written informed consent from the patient
・Any oncogene mutation (epidermal growth receptor factor, anaplastic lymphoma kinase, c-ros oncogene 1, RET, BRAF)
・Difficulty in evaluating pre-treatment nutritional/immunologic
・Active other kind of cancer
・Active infection with HIV, hepatitis B, or hepatitis C virus
・History of cancer immunotherapy
・Considered to be unsuitable for enrolment by the investigator's judgment
300
1st name | Masafumi |
Middle name | |
Last name | Yamaguchi |
National Hospital Organization Kyushu Cancer Center
Thoracic Oncology
811-1395
3-1-1, Notame, Minami-ku, Fukuoka
092-541-3231
yamaguchi.masafumi.wb@mail.hosp.go.jp
1st name | Takamori |
Middle name | |
Last name | Shinkichi |
National Hospital Organization Kyushu Cancer Center
Thoracic Oncology
811-1395
3-1-1, Notame, Minami-ku, Fukuoka
092-541-3231
shinkichi.takamori@gmail.com
National Hospital Organization
National Hospital Organization
Other
National Hospital Organization Central Review Board
2-5-21, Higashigaoka, Meguro-ku, Tokyo
03-5712-5050
700-kenkyu@mail.hosp.go.jp
NO
2020 | Year | 05 | Month | 21 | Day |
Unpublished
305
No longer recruiting
2019 | Year | 11 | Month | 18 | Day |
2019 | Year | 10 | Month | 30 | Day |
2019 | Year | 12 | Month | 20 | Day |
2024 | Year | 10 | Month | 31 | Day |
Prospective Observational Study of Nutritional/Immunologic Indices as Predictive Biomarkers to Anti-PD-1 Drugs in Non-small-Cell Lung Cancer
2020 | Year | 05 | Month | 19 | Day |
2023 | Year | 11 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046168
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |